Navigation Links
ERBE Perseveres Yet Again in Opposition to Dr. Jerome Canady, and is Awarded More Than One Million Dollars
Date:3/7/2008

Innovative Family Firm Continues to protect its Intellectual Property that has been employed in Minimally Invasive Surgical Procedures for more than

one decade

MARIETTA, Ga., March 7 /PRNewswire/ -- In a much anticipated decision, Judge Joy Flowers Conti recently ruled that Dr. Jerome Canady of McKeesport, Pennsylvania is personally liable for expenses and attorneys' fees incurred by ERBE while defending against Dr. Canady's claim that ERBE had infringed a European patent in the U.K.

On March 21, 2005 Dr. Jerome Canady sued ERBE in the United Kingdom claiming that ERBE's Argon Plasma Coagulation (APC(TM)) probes infringed European Patent No. 0595967, a foreign counterpart to Canady's U.S. Patent No. 5,207,675. Before Canady filed the U.K. case, two American courts had already found that ERBE's probes did not infringe Canady's intellectual property rights in the U.S. ERBE denied that it infringed the U.K. patent and in December 2005, the British court agreed and ordered Dr. Canady to pay ERBE more than $1M. While Dr. Canady did not dispute that he owed the money to ERBE, Dr. Canady returned to the United States without paying ERBE.

In order to collect per court decree, on March 23, 2007, ERBE filed a complaint in the United States District Court for the Western District of Pennsylvania. Since Canady had no substantive defenses, almost immediately ERBE filed a motion for summary judgment that was granted by Judge Conti on February 19, 2008. Christian O. Erbe, Managing Director of ERBE Elektromedizin GmbH, a fifth generation family owned and operated business, expects Dr. Canady to abide by Judge Conti's order.

If necessary, ERBE will aggressively seek payment from Dr. Canady, with Mr. Erbe expressing his frustration in saying, "While it may take years for full restitution, ERBE will continue to use all legal means at its disposal including garnishment, seizure of property, and/or attachment to insure Dr. Jerome Canady's debt to ERBE is paid in full per court judgment." In a previous release dated May 12, 2006 referencing the UK court ruling, Mr. Erbe avowed that "I sincerely hope that Dr. Canady will abandon his attempts to use the legal process to shake down ERBE, so that we here at ERBE can get on with our business of providing medical practitioners worldwide with innovative, quality products that optimize patient outcomes, without the time-consuming distractions of baseless litigations."

About ERBE ELEKTROMEDIZIN GmbH and ERBE USA, Inc.

ERBE ELEKTROMEDIZIN GmbH is a 161-year innovator of interventional surgical devices and the holder of many European and US Patents. Its USA subsidiary, ERBE USA, Inc. is located in Marietta, GA. ERBE is the world's leading manufacturer and distributor of Electrosurgical Units and Argon Coagulators. The company has several inventions and patents related to its APC(TM) technology used in flexible endoscopes that explore the gastrointestinal tract (esophagus, stomach, colon and small bowel) and the tracheobronchial system (trachea, bronchi and lungs) without incisions of any type. APC(TM) technology is used to treat various bleeding diseases and lesions within the aforementioned anatomy. In the case of APC(TM), ERBE first introduced this innovation to the European markets in 1992 and the United States market in 1996.

Website: http://www.erbe-usa.com/

Website: http://www.erbe-med.com/


'/>"/>
SOURCE ERBE USA, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Annie Lennox Is Stepping Up and Singing Out in the 2008 Sing Campaign Against HIV/AIDS in South Africa and Around the World
2. Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan
3. UNIFEM and Avon Announce Partnership to End Violence Against Women and Advance Womens Empowerment: Company Contribution Benefits UN Trust Fund
4. Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry
5. MSU research indicates testosterone could guard against eating disorders
6. Actor Rob Brown Rushes to Gain Ground Against Blood Cancer
7. Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
8. Dont Balance the Budget at the Expense of People With Disabilities ... Again
9. Jiffy Lube(R) Continues Drive Against Heart Disease with Maintenance Partners for Life Campaign
10. Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims
11. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... Congratulations to Head Over Heels’ elite ... 12th. Ms. Esparza qualified into this prestigious status after winning the Vault, ... Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation who ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in Miami Beach to host its Swirl: Miami Wine Tasting Event on March ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a global ... announced that Premier Research, a leading clinical development service provider, has selected ERT’s ... increasingly complex, due in part to an array of circumstances including the use ...
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only ... their upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on October ... the Virginia Mason Health System in Seattle since 2000. In addition to his role ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Medical, Inc. (NASDAQ: CGNT), a medical device company that ... urology market, will release financial results for the fourth ... the market open on Thursday, March 9, 2017. ... and webcast to discuss its financial results the same ... Eastern Time (10:00 a.m. Central Time). Darin Hammers ...
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... 2017 Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet ... der südwestlichen chinesischen Provinz Guizhou, 2017 mit dem Angebot von ... an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - ... ... ...
Breaking Medicine Technology: